1Molema G;de Leij LF;Meijer DK.Tumor vascular endothelium: barrier target in tumor dirrected drug delivery and immunotherapy,1997(01).
2Hanahan D;Folkman J.Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis[J],1996(03).
3Folkman J.Angiogenesis in cancer, vascular, rheumatoid and other disease,1995(01).
4Cao Y;Linden P;Famebo J.Vascular endothelial growth factor C induces angiogensis in vivo,1998(24).
5Folkman J.Clinical applications of research on angiogenesis,1995.
6Carron CP;Meyer DM;Pegg JA.A Peptidomimetic antagonist of the integrin alpha(v) beta 3 inhibits leydig cell tumor growth and development of hypercalcemia of malignancy,1998(09).
7Thaloor D;Singh AK;Sidhu GS.Inhibiton of angiogenic differentiation of humen umbilical vein erdothelial cells by curcumin,1998(04).
8Cao Y.Therapeutic potentials of angiostatin in the treatment of cancer,1999(07).
9Zolota V;Gerokosta A;Melachrinou M.Microvessel density,proliferating activity, p53 and bcl-2 expression in situ ductal carcinoma of the breast,1999(04).
10Kaban LB;Mulliken JB;Ezekowitz RA.Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a[J],1999(06).
2Robert S. Tumor angiogenesis: past, present and the near future[ J ]. Carcinogenesis, 2001,21 (3) : 505 - 515.
3Polkowski K, Mazurek AP. Biological properties of genistein. A review of in vitro and in vivo data[J ]. Acta Pol Pharm, 2000, 57(2) : 135 - 55.
4Sauter ER, Nasbit M, Watson JC, et 81. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck[J]. Clin Cancer Ras, 1999, 5 (4) :775 - 778.
5Petit AM. Neutralizing antibodies against epidermal growth factor and c - erbB - 2/neu receptor tyrosine kinase down regulate vascular endothelial growth production by tumor cells in vitro and in vivo:angiogenesis implicatons for signal transduction therapy of solid tumors[J]. Am J Pathol, 1997, 151 (6) : 1523 - 30.
6Shao ZM, Wu J, Shen ZZ, et al. Genistein exerts multiple suppressive effects on human breast carcinoma cells[J]. Cancer Ras, 1998, 58(21) :4851 - 4857.
7Lamartiniere CA. Protection against breast cancer with genistein: a component of soy[J ]. Am J Clin Nutrt, 2000, 71 (6 Suppl) : 1705 - 1707.
8Decaussin M, Sartelct H, Robert C, et al. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1F1t1 and VEGF-R2-F1K1/KDR) in non-small cell lung carcinoma: correlation with angiogenesis and survival. J Pathol. 1999, 188:369.
9Carron CP,Meyer DM,Pegg JA, et al.A peptidomimetic antagonist of the integrin alpha(v)beta 3 inhibits leydig cell tumor growth and the development of hypercalcemia of malignancy[J].Cancer Res,1998,58(9):1935-1939.
10Midulla C,De Iorio P,Nagar C, et al.Immunohistochemical expression of p53,nm23,ki-67 and DNA ploidy:correlation with lymph node status and other clinical pathologic parameters in breast cancer[J].Anticancer Res,1999,19(5B):4003-4007.
